论文部分内容阅读
糖尿病患者体内长期糖、脂代谢紊乱,造成全身脏器包括心脑血管、肾脏、眼等的特征性病变。糖尿病视网膜病变(diabetic retinopathy,DR)是糖尿病严重眼部并发症之一,是全世界重要的致盲原因~([1-2])。DR治疗的基础及临床研究为科学合理地选择治疗方式和时机提供了更多的循证医学证据。现将治疗DR的临床研究新进展综述如下。1基础疾病的治疗糖尿病、高血压、高血脂三大疾病可谓相互关联、互相影响,共同作用于人体的靶器官,影响最为
Diabetic patients with long-term sugar, lipid metabolism disorders, resulting in systemic organs, including cardiovascular and cerebrovascular, kidney, eye and other characteristic lesions. Diabetic retinopathy (DR) is one of the serious ocular complications of diabetes mellitus, which is an important cause of blindness worldwide [1-2]. The basic and clinical research of DR treatment provides more evidence-based medical evidence for choosing the treatment method and timing scientifically and rationally. Now the clinical progress of the treatment of DR new progress are summarized below. 1 The treatment of underlying diseases Diabetes, hypertension, hyperlipidemia can be described as the three major diseases linked to each other, the common target role in the human body, the most affected